Results 171 to 180 of about 163,099 (316)
An Overview of Phase-Locked Loop: From Fundamentals to the Frontier. [PDF]
Nguyen TVH, Pham CK.
europepmc +1 more source
Analog signal multiplexing for PSAPD-based PET detectors: simulation and experimental validation [PDF]
Frances Lau +5 more
openalex +1 more source
ABSTRACT Objective Autosomal dominant progranulin (GRN) pathogenic variants are a genetic cause of frontotemporal lobar degeneration. Though clinical trials for GRN‐related therapies are underway, there is an unmet need for biomarkers that can predict symptom onset and track disease progression.
Taru M. Flagan +46 more
wiley +1 more source
Ultrahigh-precision analog computing using memory-switching geometric ratio of transistors. [PDF]
Yangdong XJ +16 more
europepmc +1 more source
ABSTRACT Objective Cognitive impairment (CI) affects the quality of life in multiple sclerosis (MS). Identifying influencing factors is key to improving CI monitoring. This systematic review and meta‐analysis examines clinical and sociodemographic variables impacting the cognitive screening Symbol Digit Modalities Test (SDMT) performance across MS ...
Katalin Lugosi +8 more
wiley +1 more source
Vector analog computing via on-demand metasurface dispersive polarization transformation. [PDF]
Yang H +10 more
europepmc +1 more source
Longitudinal changes in salivary biomarkers in Parkinson’s disease (PD) from early (T0) to 4‐year follow‐up (T1), quantified by ELISA: oligomeric and total α‐synuclein, total and phosphorylated tau, MAP1LC3B (autophagy), and TNFa (inflammation). Blue arrows indicate direction of change at T1 vs T0 (up = increase; down = decrease).
Maria Ilenia De Bartolo +13 more
wiley +1 more source
Audio Interference Suppressor in Analog Audio Interface. [PDF]
Olujić V, Fajt S, Sruk V, Krhen M.
europepmc +1 more source
Differential Difference Current Conveyor Transconductance Amplifier: A New Analog Building Block for Signal Processing [PDF]
Neeta Pandey, Sajal K. Paul
openalex +1 more source
ABSTRACT Objective Facioscapulohumeral muscular dystrophy type 1 (FSHD1) is a progressive neuromuscular disorder with no approved treatments. Identifying reliable biomarkers is critical to monitor disease severity, activity, and progression. Interleukin‐6 (IL‐6) has been proposed as a candidate biomarker, but longitudinal validation is limited ...
Jonathan Pini +13 more
wiley +1 more source

